C World Wide Group Holding A Intra Cellular Therapies, Inc. Transaction History

C World Wide Group Holding A

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$10.65 - $14.29 $1.56 Million - $2.1 Million	-146,671 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$10.36 - $20.96 $539,051 - $1.09 Million	-52,032 Reduced 26.19%	146,671 $1.67 Million
Q3 2018 Nov 05, 2018	BUY	$17.77 - $22.9 $445,085 - $573,576	25,047 Added 14.42%	198,703 $4.31 Million
Q2 2018 Aug 03, 2018	BUY	$17.33 - $23.4 $628,264 - $848,320	36,253 Added 26.38%	173,656 $3.07 Million
Q1 2018 May 03, 2018	SELL	$15.16 - $25.49 $1.29 Million - $2.17 Million	-85,107 Reduced 38.25%	137,403 $2.89 Million
Q4 2017 Feb 07, 2018	SELL	$14.27 - $16.79 $280,348 - $329,856	-19,646 Reduced 8.11%	222,510 $3.22 Million
Q3 2017 Nov 06, 2017	BUY	$10.77 - $22.1 $2.61 Million - $5.35 Million	242,156	242,156 $3.82 Million

379

84M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.